Roche RHHBY announced today that the FDA has approved a label expansion of ophthalmology drug Susvimo (ranibizumab injection). The regulatory body approved the drug Susvimo for the treatment of ...

German drugmaker Bayer on Friday won an endorsement by the European Medicines Agency to extend the intervals between shots of ...

An EMA committee has issued a positive opinion for a label extension that would allow six-month injection intervals for Eylea ...

Ophthalmology Times - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic ...

Intraocular inflammation occurred more frequently with 8-mg aflibercept (Eylea) compared with what ... Today that "inflammation after intravitreal injections can sometimes be from endophthalmitis ...

Eylea. The standard version of the anti-VEGF intravitreal injection delivered $1.4B in net product sales for the company in Q1, indicating a ~29% YoY drop and missing $1.8B projected by analysts ...

Important Safety Information: EYLEA HD and EYLEA are administered via intravitreal injection. Patients should not use EYLEA HD if they have ocular or periocular infections, active intraocular ...

It is highly similar to the reference product Eylea® (aflibercept ... with or without occlusion may occur following intravitreal injections. Patients and/or caregivers should be instructed ...

You have permission to edit this article. Edit Close Activate Subscribe My Account Logout Login/Register ...

3 Three principle treatment options for MO secondary to BRVO are discussed in the Royal College of Ophthalmologists’ guidelines: macular laser, intravitreal injections of anti ... (Lucentis), and ...

The randomized, sham-controlled Phase III trial, dubbed ARTEMIS, is a non-inferiority study, in which researchers are comparing a single dose of ixo-vec administered with an intravitreal injection ...

EyePoint's Duravyu, a potential "best-in-class" therapy for Wet AMD and DME, could disrupt the market with fewer injections required compared to Eylea and Vabysmo. Positive Phase 2 DME data and ...